Buhmeida A - Search Results

1

Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques.

Nedjadi T, Al-Maghrabi J, Assidi M, Dallol A, Al-Kattabi H, Chaudhary A, Al-Sayyad A, Al-Ammari A, Abuzenadah A, Buhmeida A, Al-Qahtani M. Nedjadi T, et al. Among authors: buhmeida a. BMC Cancer. 2016 Aug 19;16:653. doi: 10.1186/s12885-016-2703-5. BMC Cancer. 2016. PMID: 27539085 Free PMC article.

2

Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.

Buhmeida A, Bendardaf R, Hilska M, Collan Y, Laato M, Syrjänen S, Syrjänen K, Pyrhönen S. Buhmeida A, et al. J Gastrointest Cancer. 2009;40(3-4):91-7. doi: 10.1007/s12029-009-9091-x. J Gastrointest Cancer. 2009. PMID: 19921474

3

Nuclear morphometry in prognostication of breast cancer in Saudi Arabian patients: comparison with European and African breast cancer.

Buhmeida A, Al-Maghrabi J, Merdad A, Al-Thubaity F, Chaudhary A, Gari M, Abuzenadah A, Collan Y, Syrjänen K, Al-Qahtani M. Buhmeida A, et al. Anticancer Res. 2010 Jun;30(6):2185-91. Anticancer Res. 2010. PMID: 20651368

4

Evaluation of HER-2/neu gene amplification by fluorescence in situ hybridization and immunohistochemistry in saudi female breast cancer.

Al-Khattabi H, Kelany A, Buhmeida A, Al-Maghrabi J, Lari S, Chaudhary A, Gari M, Abuzenadah A, Al-Qahtani M. Al-Khattabi H, et al. Among authors: buhmeida a. Anticancer Res. 2010 Oct;30(10):4081-8. Anticancer Res. 2010. PMID: 21036723

5

Prognostic value of mitotic counts in breast cancer of Saudi Arabian patients.

Buhmeida A, Al-Maghrabi J, Merdad A, Al-Thubaity F, Chaudhary A, Gari M, Abuzenadah A, Collan Y, Syrjänen K, Al-Qahtani M. Buhmeida A, et al. Anticancer Res. 2011 Jan;31(1):97-103. Anticancer Res. 2011. PMID: 21273586

6

Expression of cell cycle regulators p21 and p27 as predictors of disease outcome in colorectal carcinoma.

Al-Maghrabi J, Al-Ahwal M, Buhmeida A, Syrjänen K, Sibyani A, Emam E, Ghanim A, Al-Qahtani M. Al-Maghrabi J, et al. Among authors: buhmeida a. J Gastrointest Cancer. 2012 Jun;43(2):279-87. doi: 10.1007/s12029-011-9292-y. J Gastrointest Cancer. 2012. PMID: 21637966

7

RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency.

Buhmeida A, Merdad A, Al-Maghrabi J, Al-Thobaiti F, Ata M, Bugis A, Syrjänen K, Abuzenadah A, Chaudhary A, Gari M, Al-Qahtani M, Dallol A. Buhmeida A, et al. Anticancer Res. 2011 Sep;31(9):2975-81. Anticancer Res. 2011. PMID: 21868547

8

Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma.

Al-Maghrabi J, Buhmeida A, Emam E, Syrjänen K, Sibiany A, Al-Qahtani M, Al-Ahwal M. Al-Maghrabi J, et al. Among authors: buhmeida a. World J Gastroenterol. 2012 Apr 21;18(15):1793-9. doi: 10.3748/wjg.v18.i15.1793. World J Gastroenterol. 2012. PMID: 22553404 Free PMC article.

9

Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma.

Al-Maghrabi J, Gomaa W, Buhmeida A, Al-Qahtani M, Al-Ahwal M. Al-Maghrabi J, et al. Among authors: buhmeida a. Anticancer Res. 2012 Aug;32(8):3455-61. Anticancer Res. 2012. PMID: 22843930

10

Methylation of the polycomb group target genes is a possible biomarker for favorable prognosis in colorectal cancer.

Dallol A, Al-Maghrabi J, Buhmeida A, Gari MA, Chaudhary AG, Schulten HJ, Abuzenadah AM, Al-Ahwal MS, Sibiany A, Al-Qahtani MH. Dallol A, et al. Among authors: buhmeida a. Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2069-75. doi: 10.1158/1055-9965.EPI-12-0755. Epub 2012 Sep 25. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 23010642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters